• Susan G. Komen’s go-to resource in the commonwealth of Pennsylvania.
• Participating in state/federal public policy initiatives.
• Funding the mission of Komen by participating in the full cycle of development planning and plan execution to meet revenue goals and objectives.
• Embracing Susan G. Komen as one of their top charities of choice.
• Assist with the performance and development of Executive Director.
• Solidify relationships with industry/HNW/Individual Donors who can help PANO as an organization

• Set the foundation’s strategic growth strategy and direction for two business units (Copay & NewCo)
• Accelerated fundraising performance by generating copay revenue to exceed baseline of $276mil to reach $300mil in 2023, highest the Foundation has seen in the past three years.
• Built a repository of 1,000+ donors and established relationships with UHNW/VHNW donors.
• Bolstered and renewed relationships in the Big Pharma community and nonprofit alliance partners.
• Networked conferences to build new and reestablish relationships with the key donors and investors.
• Built cross-functional C-Suite and Board relationships to further the Foundations strategy and growth.

• Developing Strategic Partnerships: PE/VC/Family Office/High-Net Worth Investors
• In charge of capital acquisition and management (e.g. reviewing from start to finish investment allocation and review process)
• Assist with Deal Flow (Sourcing, Specialization and Evaluation)
• Developing business development strategies and investor acquisition strategies/Investor Relations
• Involved in portfolio company development (e.g. Impact Measurement, Tailored Value Add, Leadership). Also including mergers and acquisition opportunities.
• Building a network of institutional investors that strengthens the fund's development and future capital requirements.

• Angel Investor, Founder, Business Mentor.
• Investor relations, Portfolio Management.
• Strategic Partnerships: PE/VC/Family Office (Capital Formation/Fundraising/Exit Strategy
• Facilitation Mergers & Acquisitions
• Commercial Operations Strategies: Pricing, Profit Margin Management, Valuation Strategies
• Value Proposition Infrastructure and Investor Attractiveness Strategy
• Portfolio Companies: Dovizia Pharma Services/LabME (Singapore), Koolboks (Nigeria), iMetabolic Biopharma (USA), Intus (USA).

• Led a 250-member team with 12 direct reports (Country Directors) across 12 countries.
• Identified and help to invest and secure (micro-financing) investment capital for local farmers to ensure healthy infrastructure for livestock.
• Worked with and partnered with several global agencies (e.g. WHO) on animal health and proper poultry maintenance practices.
• Built and implemented a farming market financing plan that achieved a 98% top line revenue growth with wholesale/distributor accounts for new product Closamectin Pour-On and achieved organizational budget of $700 million.
• Responsible for corporate licensing and business development operations.
• Along with Chairman developed pricing plan, marketing positioning/market research strategies and SFE strategies for various products which helped to increase new animal healthcare device products.

Built and led the entire infrastructure of the BioPharm sales operations department from ground level up.
• Managing a $25 Million dollar budget
• As operations head, instituted SFE digitial tools for business development group and increased account development performance (before implementation 89% after implementation 119%
• Building and executing BD analytics, call planning, customer segmentation processes for 3 categories of business (Hemophilia-Oncology/ Woman's Healthcare/ Growth Hormone)
• Created a

Created and implemented best in class global marketing/digital tools and technologies for new pain franchise product (IONSYS Post-Op System).
• Developed comprehensive strategic marketing and business development initiatives for hospital & account base sales forces (total of 1000 field personnel)
• Led the development of branding/product core messaging and market research utilizing process excellence principles (e.g. KOL development, CRNA/Anesthesiology Focus Groups/Customer Segmentation Studies)
• Managing a $50 Million dollar budget, and its P&L.
• Successfully managed 15 vendor contract projects and ensured training/marketing initiatives were delivered on time and within budget. Developed the

Led and managed a nation of field and hospital business development managers that specialized in promoting oncology hospital-based products to national teaching hospitals and hospital health systems (In addition government agencies-Veterans Administration, Department of Defense, Managed Care Organizations).
● • Successfully managed a $150 million budget and consistently surpassed goal attainment at 115%/year
• Successful in achieving 15 large contracts and hospital/hospital system/MCO formulary additions
• Chiefly responsible for coaching/development of regional directors and their direct reports; achieved 17 promotions during tenure
• Managed a multi-million dollar team budget (Markets: Pain Management/Oncology,)
• Management of group purchasing organizations (GPO's) to insure hospital product access
• Managed and successfully pull-through of National MCO wins (Aetna, Humana, United Healthcare)
• Created hospital buying process strategy to help our team understand how to establ